AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team
AUAUniversity30 Apr 2025

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team CME Available: https://auau.auanet.org/node/42822 At the conclusion of this CME activity, participants will be able to: 1. Apply the mechanism of action of PARP inhibitors and the rationale for using them in patients with advanced prostate cancer. 2. Recognize the role and importance of genetic testing in patients with mCRPC and the implications of germline mutations on response to therapy. 3. Identify best practices and utilize available guidelines for patients with mCRPC to optimize treatment success and oncologic outcomes. 4. Recognize when to use PARP inhibitors as monotherapy, the rationale and indications for combination therapy, and appropriate treatment sequencing. 5. Successfully counsel patients on the possible adverse events associated with PARP inhibitor therapies alone or in combination. ACKOWLEDGEMENTS Support provided by independent educational grants from: AstraZeneca Merck & Co., Inc.

Episoder(421)

AUA2021 Ramon Guiteras Lecture - Three Decades Of Bladder Cancer Treatment: Progress And Promise

AUA2021 Ramon Guiteras Lecture - Three Decades Of Bladder Cancer Treatment: Progress And Promise

Speaker: Eila C. Skinner, MD

19 Jan 202220min

AUA2021 John K. Lattimer Lecture - Kidney Stones: Is Prevention Possible?

AUA2021 John K. Lattimer Lecture - Kidney Stones: Is Prevention Possible?

Title: AUA2021 John K. Lattimer Lecture - Kidney Stones: Is Prevention Possible? Speaker: Glenn M. Preminger, MD Release: January 12

12 Jan 202220min

Testis Cancer – Apply the Guidelines to Clinical Practice

Testis Cancer – Apply the Guidelines to Clinical Practice

Host: Jay Raman, MD, FACS Co-host: Scott Eggener, MD

5 Jan 202231min

How to Safely and Properly Administer Immunotherapies

How to Safely and Properly Administer Immunotherapies

How to Safely and Properly Administer Immunotherapies Podcast (2021) CME Available: https://auau.auanet.org/node/33496 ACKNOWLEDGEMENTS This educational series is supported by independent educationa...

29 Des 202133min

Management of Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies

Management of Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies

Management of Advanced Kidney Cancer: A Guide to Targeted Agents and Immunotherapies Podcast (2021) CME Available: auau.auanet.org/node/33488 ACKNOWLEDGEMENTS This educational series is supported by...

23 Des 202140min

Peer-Reviewed Guidance on How to Manage Immune-Related Adverse Events & Toxicities

Peer-Reviewed Guidance on How to Manage Immune-Related Adverse Events & Toxicities

Peer-Reviewed Guidance on How to Manage Immune-Related Adverse Events & Toxicities Podcast (2021) CME Available: auau.auanet.org/node/33492 This educational series is supported by independent educat...

15 Des 202143min

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Update

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Update

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Update Podcast (2021) CME Available: auau.auanet.org/node/33467 This educational series is supported by independent educational grants from: Astella...

8 Des 202138min

How Can We Improve SDM  A Prostate Cancer Survivor’s Perspective

How Can We Improve SDM A Prostate Cancer Survivor’s Perspective

Support provided by independent educational grants from Astellas, Bayer HealthCare Pharmaceuticals Inc., Genentech, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., Merck and P...

1 Des 202134min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
rss-strid-de-norske-borgerkrigene
foreldreradet
jakt-og-fiskepodden
rss-sunn-okonomi
smart-forklart
sinnsyn
tomprat-med-gunnar-tjomlid
merry-quizmas
hverdagspsyken
dopet
gravid-uke-for-uke
rss-var-forste-kaffe
rss-kunsten-a-leve
rss-adhd-i-klasserommet
podme-bio-3
sovnlos